8-K/A
Current Report
ArriVent BioPharma, Inc. Filed Acc 0001104659-24-078587
Executive or director change
- Item 5.02 Departure or appointment of directors or officers
From the SEC's structured data for this filing
Loading tm2419108d2_8ka.htm…